Dr Reddy’s to launch Optidoz – a drug for hypertension
Efficacy and safety of Optidoz has been established through the CONTROL-Hypertension clinical study
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon Academy’s starts flagship programme in collaboration with KGI
The 16-week, full-time Biocon KGI certificate programme will be delivered by renowned faculty from KGI and Biocon Academy
US FDA approves first gel for sealing corneal incision after cataract surgery
The ReSure Sealant kit comes as two liquid solutions that the surgeon mixes together just prior to sealing the incision
Business Monitor releases report on India’s pharmaceuticals and healthcare sector
Report mentions that the government is impeding the development of its pharma sector, mainly due to extensive bureaucracy and poor…
Breast cancer risk can be significantly decreased by maintaining optimal vitamin D levels: Study
Breast tissue cells bear special surface receptors that are designed to absorb Vitamin D
Ranbaxy and EPIRUS sign licensing agreement for biosimilar product
Ranbaxy to market in India and other emerging markets, after approval
New development paradigms key to company success: Tufts Center for the Study of Drug Development
Clinical design improvements and new partnership models will help development of industry best practices
Ranbaxy receives approval to market RAN-Donepezil in Canada
Is indicated in the treatment of dementia in Alzheimer’s patients
GE acquires strategic assets from Thermo Fisher Scientific to expand in life sciences
Extends bioprocessing manufacturing footprint in Asia, the Americas and Europe